Home
XLO
XLO News

Latest Xilio Therapeutics Inc. (XLO) News on November 25, 2025

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results

GlobeNewswire

12 days ago

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results

BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Misses Revenue Estimates

Zacks

13 days ago

BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Misses Revenue Estimates

Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

GlobeNewswire

18 days ago

Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

GlobeNewswire

18 days ago

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

22 days ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wall Street says tokenization will change global markets. Gold is next.

Yahoo Finance

24 days ago

Wall Street says tokenization will change global markets. Gold is next.

US negotiating power is strong across the globe, except in China

Yahoo Finance Video

24 days ago

US negotiating power is strong across the globe, except in China

DeepSeek, Qwen AI Besting ChatGPT, Grok, Gemini In AI Crypto Trading Challenge

Benzinga

24 days ago

DeepSeek, Qwen AI Besting ChatGPT, Grok, Gemini In AI Crypto Trading Challenge

Furloughed federal workers face delays getting unemployment pay during shutdown

Associated Press Finance

24 days ago

Furloughed federal workers face delays getting unemployment pay during shutdown

Veralto Corporation (NYSE:VLTO) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Simply Wall St.

24 days ago

Veralto Corporation (NYSE:VLTO) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

The No. 1 Reason New Businesses Fail, According to a Shark Tank Investor

GOBankingRates

24 days ago

The No. 1 Reason New Businesses Fail, According to a Shark Tank Investor

Ryerson Holding (NYSE:RYI) Is Due To Pay A Dividend Of $0.1875

Simply Wall St.

24 days ago

Ryerson Holding (NYSE:RYI) Is Due To Pay A Dividend Of $0.1875

2 Big Tech Stocks Just Announced Stock Splits. Here's What You Need to Know.

Motley Fool

24 days ago

2 Big Tech Stocks Just Announced Stock Splits. Here's What You Need to Know.

Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting

GlobeNewswire

a month ago

Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting

AI will 'amplify, not replace' human performance: Workday CEO

Yahoo Finance Video

a month ago

AI will 'amplify, not replace' human performance: Workday CEO

'Premature to signal the all-clear': Markets cheered the CPI print — but Main Street isn’t feeling the relief

Yahoo Finance

a month ago

'Premature to signal the all-clear': Markets cheered the CPI print — but Main Street isn’t feeling the relief

Grant Cardone Lays Out Why His Bitcoin Real Estate Hybrid Model Will Crush REITs

Benzinga

a month ago

Grant Cardone Lays Out Why His Bitcoin Real Estate Hybrid Model Will Crush REITs

Media Advisory - Monday, October 27, 2025

CNW Group

a month ago

Media Advisory - Monday, October 27, 2025

Israel insists it calls shots in Gaza despite truce

AFP

a month ago

Israel insists it calls shots in Gaza despite truce

Bitcoin’s Path To $120,000 Could Be Delayed as Illiquid Supply Shrinks

BeInCrypto

a month ago

Bitcoin’s Path To $120,000 Could Be Delayed as Illiquid Supply Shrinks

Walmart’s award-winning $168 Viktor & Rolf perfume with 4,300+ perfect ratings is on sale for only $78

TheStreet

a month ago

Walmart’s award-winning $168 Viktor & Rolf perfume with 4,300+ perfect ratings is on sale for only $78

Could Investing $10,000 in Rigetti Computing Make You a Millionaire?

Motley Fool

a month ago

Could Investing $10,000 in Rigetti Computing Make You a Millionaire?

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

GlobeNewswire

5 months ago

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

GlobeNewswire

6 months ago

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering

GlobeNewswire

6 months ago

Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering

Xilio Therapeutics Announces Proposed Public Offering

GlobeNewswire

6 months ago

Xilio Therapeutics Announces Proposed Public Offering

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

GlobeNewswire

6 months ago

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results

GlobeNewswire

7 months ago

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting

GlobeNewswire

7 months ago

Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics, Inc. (XLO) Reports Q4 Loss, Lags Revenue Estimates

Zacks

9 months ago

Xilio Therapeutics, Inc. (XLO) Reports Q4 Loss, Lags Revenue Estimates

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

9 months ago

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Xilio Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

GlobeNewswire

9 months ago

Xilio Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs

Zacks

9 months ago

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs

AbbVie and Xilio to collaborate on antibody-based immunotherapies

Pharmaceutical Technology

9 months ago

AbbVie and Xilio to collaborate on antibody-based immunotherapies

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?

Benzinga

9 months ago

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?

MT Newswires

9 months ago

AbbVie, Xilio Collaborate on Tumor-Activated Immunotherapies

Xilio Therapeutics Announces Multiple Masked T Cell Engager Programs

GlobeNewswire

9 months ago

Xilio Therapeutics Announces Multiple Masked T Cell Engager Programs

GlobeNewswire

9 months ago

AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

10 months ago

Xilio Therapeutics Phase 2 Study of Vilastobart Plus Atezolizumab Demonstrates 27% Response Rate in Colorectal Cancer

Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

GlobeNewswire

10 months ago

Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI

GlobeNewswire

a year ago

Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI

Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer

GlobeNewswire

a year ago

Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer

After Golden Cross, Xilio Therapeutics, Inc. (XLO)'s Technical Outlook is Bright

Zacks

a year ago

After Golden Cross, Xilio Therapeutics, Inc. (XLO)'s Technical Outlook is Bright

Here's Why We're Not Too Worried About Xilio Therapeutics' (NASDAQ:XLO) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About Xilio Therapeutics' (NASDAQ:XLO) Cash Burn Situation

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Initial Clinical Trial Data from Phase 1C Dose Escalation for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Advanced Solid Tumors

GlobeNewswire

a year ago

Xilio Therapeutics Announces Initial Clinical Trial Data from Phase 1C Dose Escalation for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Advanced Solid Tumors

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results

GlobeNewswire

a year ago

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results

Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

GlobeNewswire

a year ago

Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

GlobeNewswire

a year ago

Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

GlobeNewswire

a year ago

Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results

Can Xilio Therapeutics (NASDAQ:XLO) Afford To Invest In Growth?

Simply Wall St.

a year ago

Can Xilio Therapeutics (NASDAQ:XLO) Afford To Invest In Growth?

Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors

GlobeNewswire

a year ago

Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors

Start Proud Opens the Market

CNW Group

a year ago

Start Proud Opens the Market

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Associated Press Finance

a year ago

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Business Wire

a year ago

Form 8.3 - Darktrace plc

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

Investor's Business Daily

a year ago

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

May jobs reports signals Fed's soft landing: US Labor Secretary

Yahoo Finance Video

a year ago

May jobs reports signals Fed's soft landing: US Labor Secretary

Notification of major holding in Kindred Group plc

PR Newswire

a year ago

Notification of major holding in Kindred Group plc

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

a year ago

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

a year ago

Form 8.3 - DS Smith plc

Gilead and Cartography enter deal to develop cancer therapies

Pharmaceutical Technology

a year ago

Gilead and Cartography enter deal to develop cancer therapies

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results

GlobeNewswire

2 years ago

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results

Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why

Zacks

2 years ago

Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

2 years ago

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing

GlobeNewswire

2 years ago

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

Business Wire

2 years ago

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

Gilead bets on Xilio cancer drug as biotech restructures

BioPharma Dive

2 years ago

Gilead bets on Xilio cancer drug as biotech restructures

Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference

GlobeNewswire

2 years ago

Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference

Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference

GlobeNewswire

2 years ago

Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference

SPAR Group (NASDAQ:SGRP) Is Very Good At Capital Allocation

Simply Wall St.

2 years ago

SPAR Group (NASDAQ:SGRP) Is Very Good At Capital Allocation

Can Flexsteel (FLXS) Run Higher on Rising Earnings Estimates?

Zacks

2 years ago

Can Flexsteel (FLXS) Run Higher on Rising Earnings Estimates?

Smart Sand (NASDAQ:SND) Could Be Struggling To Allocate Capital

Simply Wall St.

2 years ago

Smart Sand (NASDAQ:SND) Could Be Struggling To Allocate Capital

Horizon Aircraft Enters into Letter of Intent to Purchase $250M of Cavorite X7 Aircraft, with an Option for up to $500M

GlobeNewswire

2 years ago

Horizon Aircraft Enters into Letter of Intent to Purchase $250M of Cavorite X7 Aircraft, with an Option for up to $500M

Beam Global CEO Desmond Wheatley Recognized as Business Intelligence Group’s Global Sustainability Hero of the Year

GlobeNewswire

2 years ago

Beam Global CEO Desmond Wheatley Recognized as Business Intelligence Group’s Global Sustainability Hero of the Year

Kingstone CEO Letter to Shareholders

ACCESSWIRE

2 years ago

Kingstone CEO Letter to Shareholders

Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies

GlobeNewswire

2 years ago

Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies

FG Financial Group, Inc. and FG Group Holdings Inc. Sign Definitive Plan of Merger to form Fundamental Global Inc.

GlobeNewswire

2 years ago

FG Financial Group, Inc. and FG Group Holdings Inc. Sign Definitive Plan of Merger to form Fundamental Global Inc.

Kopin to Ring Nasdaq Closing Bell on January 16th

Business Wire

2 years ago

Kopin to Ring Nasdaq Closing Bell on January 16th

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

PR Newswire

2 years ago

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

Business Wire

2 years ago

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

Burning Rock Announces Results of 2023 Annual General Meeting

GlobeNewswire

2 years ago

Burning Rock Announces Results of 2023 Annual General Meeting

We Like These Underlying Return On Capital Trends At L.S. Starrett (NYSE:SCX)

Simply Wall St.

2 years ago

We Like These Underlying Return On Capital Trends At L.S. Starrett (NYSE:SCX)

GreenPower Delivers Four Nano BEAST All-Electric, School Buses to West Virginia School Districts

PR Newswire

2 years ago

GreenPower Delivers Four Nano BEAST All-Electric, School Buses to West Virginia School Districts

There’s an EV Delivery Event Today. It’s Different From the Cybertruck One.

Barrons.com

2 years ago

There’s an EV Delivery Event Today. It’s Different From the Cybertruck One.

IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement

GlobeNewswire

2 years ago

IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement

Xilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Data

GlobeNewswire

2 years ago

Xilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Data

DLH Reports Fiscal 2023 Fourth Quarter Results

GlobeNewswire

2 years ago

DLH Reports Fiscal 2023 Fourth Quarter Results

Odyssey Marine Exploration Secures Strategic Debt Financing Deal

Business Wire

2 years ago

Odyssey Marine Exploration Secures Strategic Debt Financing Deal

Business Wire

2 years ago

Vince Holding Corp. Announces Participation in the Sidoti Small Cap Conference

Business Wire

2 years ago

Vince Holding Corp. Announces New Chief Financial Officer

Ralph Lauren veteran takes CFO job at Vince

Retail Dive

2 years ago

Ralph Lauren veteran takes CFO job at Vince

Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023

GlobeNewswire

2 years ago

Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023

Share on Social Networks: